Suchergebnisse - "Sarilumab"

PubPharm (143)

71

Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients : SARTRE: a structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Caballero Bermejo, A. | Ruiz-Antorán, B. | Fernández Cruz, A. | +7

72

Investigational Therapies for the Treatment of COVID-19 : Updates from Ongoing Clinical Trials

enthalten in: European urology focus | 2020

von Abrams-Downey, A. | Saabiye, J. | Vidaurrazaga, M.

73

Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID) : a structured summary of a study protocol for a randomised controlled trial

enthalten in: Trials | 2020

von Garcia-Vicuña, R. | Abad-Santos, F. | González-Alvaro, I. | +2

74

IL-6 (Interleukin 6) Blockade and Heart Rate Corrected QT Interval Prolongation in COVID-19

enthalten in: Circulation. Arrhythmia and electrophysiology | 2020

von Lazzerini, P. | Laghi-Pasini, F. | Acampa, M. | +2

75

Additive treatment considerations in COVID-19-The clinician's perspective on extracorporeal adjunctive purification techniques

enthalten in: Artificial organs | 2020

von Swol, J. | Lorusso, R.

76

Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19

enthalten in: Paediatric respiratory reviews | 2020

von Tanner, T. | Wahezi, D.

77

Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19 : Rationale, Clinical Evidence and Risks

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2020

von Crisafulli, S. | Isgrò, V. | La Corte, L. | +2

78

Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

enthalten in: Journal for immunotherapy of cancer | 2020

von Montesarchio, V. | Parrela, R. | Iommelli, C. | +18

ErratumIn: J Immunother Cancer. 2020 Sep;8(2):. - PMID 32895295

79

Retrospective analysis of high flow nasal therapy in COVID-19-related moderate-to-severe hypoxaemic respiratory failure

enthalten in: BMJ open respiratory research | 2020

von Patel, M. | Gangemi, A. | Marron, R. | +14

80

Industry update : the latest developments in the field of therapeutic delivery, March 2020

enthalten in: Therapeutic delivery | 2020

von Timmins, P.